James Harvey1, Julia Henderson2, Lopa Patel2, John Murphy2, Richard Johnson2. 1. Nightingale Centre, University Hospital of South Manchester, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK; University of Manchester, Manchester M13 9PL, UK. Electronic address: James.Harvey@uhsm.nhs.uk. 2. Nightingale Centre, University Hospital of South Manchester, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK.
Abstract
UNLABELLED: Therapeutic mammaplasty allows breast conservation and maintains breast cosmesis in women with larger and ptotic breasts. They are associated with more post-operative complications, potentially delaying adjuvant treatment. Our aim is to investigate the impact of therapeutic mammaplasty on the timing of adjuvant chemotherapy, compared with conventional breast conservation surgery. METHODS: Retrospective data collection of breast cancer patients undergoing breast-conserving surgery at a single institution from 2009 to 2013. RESULTS: 1000 patients underwent breast-conserving surgery, 40 underwent therapeutic mammaplasty. Patients with a complication of mammaplasty had no delay to starting chemotherapy compared to those without complication (median 36 vs. 40 days). There was no delay to chemotherapy for patients requiring further breast cancer excision surgery following therapeutic mammaplasty compared with standard breast conservation surgery (36 vs. 39 days). CONCLUSIONS: There is no delay in commencing adjuvant chemotherapy following therapeutic mammaplasty surgery, even if there is a complication of surgery. However, patients with involved margins had a significant delay to chemotherapy whilst awaiting re-excision surgery.
UNLABELLED: Therapeutic mammaplasty allows breast conservation and maintains breast cosmesis in women with larger and ptotic breasts. They are associated with more post-operative complications, potentially delaying adjuvant treatment. Our aim is to investigate the impact of therapeutic mammaplasty on the timing of adjuvant chemotherapy, compared with conventional breast conservation surgery. METHODS: Retrospective data collection of breast cancerpatients undergoing breast-conserving surgery at a single institution from 2009 to 2013. RESULTS: 1000 patients underwent breast-conserving surgery, 40 underwent therapeutic mammaplasty. Patients with a complication of mammaplasty had no delay to starting chemotherapy compared to those without complication (median 36 vs. 40 days). There was no delay to chemotherapy for patients requiring further breast cancer excision surgery following therapeutic mammaplasty compared with standard breast conservation surgery (36 vs. 39 days). CONCLUSIONS: There is no delay in commencing adjuvant chemotherapy following therapeutic mammaplasty surgery, even if there is a complication of surgery. However, patients with involved margins had a significant delay to chemotherapy whilst awaiting re-excision surgery.
Authors: Francesca De Lorenzi; Francesco Borelli; Mario Alessandri-Bonetti; Alberto Marchetti; Leonardo Pires Novais Dias; Alessandra Invento; Elisabetta Maria Cristina Rossi; Pietro Loschi; Paolo Veronesi Journal: Aesthetic Plast Surg Date: 2022-10-19 Impact factor: 2.708
Authors: Pietro M Ferrando; Ada Ala; Riccardo Bussone; Laura Bergamasco; Federica Actis Perinetti; Fabrizio Malan Journal: Plast Reconstr Surg Glob Open Date: 2018-06-15
Authors: Alice Lee; Richard M Kwasnicki; Hasaan Khan; Yasmin Grant; Abigail Chan; Angela E E Fanshawe; Daniel R Leff Journal: BJS Open Date: 2021-11-09